Using a mouse model of obesity in pregnancy, Aye et al. further confirmed that maternal adiponectin supplementation prevents foetal overgrowth caused by maternal obesity by the inhibition of placental insulin and mTORC1 signalling resulting in normalisation of placental nutrient transport [138]. The gene discussed is ADIPOQ; the disease is obesity disorder.